MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Deep Brain Stimulation in Generalized Dystonia Caused by PRKRA Mutation

A. Falcone, C. Listik, S. Barbosa Casagrande, M. Torres, D. Boari Coelho, L. Augusto Teixeira, J. Papaterra Limongi, M. Jacobsen Teixeira, E. Reis Barbosa, R. Cury (Caçapava, Brazil)

Meeting: 2022 International Congress

Abstract Number: 287

Keywords: Deep brain stimulation (DBS), Dystonia: Genetics, Dystonia: Treatment

Category: Surgical Therapy: Other Movement Disorders

Objective: Dystonia is a hyperkinetic movement disorder with a complex pathophysiology. The medical treatment includes pharmacological treatment, including botulinum toxin (BoNT), which is considered the first-line therapy for focal and segmental dystonia1. The available clinical treatments promote symptom relief but have limited efficacy and systemic side effects. For refractory symptoms, globus pallidus internus (GPi) or the subthalamic nucleus (STN) deep brain stimulation (DBS) can be indicated.

Background: The current evidence for DBS ranges from class I evidence for isolated generalized dystonia to class IV evidence for some acquired combined dystonia (3). Moreover, the responsiveness varies among the monogenetic causes, with good evidence for DYT-TOR1A (DYT1), DYT-SCGE (DYT11), and DYT-TAF1 (DYT3), moderate results in DYT-THAP1 (DYT6) and poor response in DYT-ATP1A3 (DYT-12). 
The recent DYT16, a monogenetic autosomal recessive dystonia with parkinsonism, was described with a mutation in the PRKRA gene. The clinical phenotype is of a generalized dystonia, typically with involvement of the neck and trunk muscles to a greater extent than then limbs; it has oromandibular and laryngeal dystonia and parkinsonism that is not levodopa-responsive. Patients with DYT-PRKRA also do not respond well to anticholinergics.

Method: Here we describe three patients with DYT-PRKRA with refractory symptoms treated with GPi DBS. The patients were assessed by the Burke–Fahn–Marsden Dystonia Rating Scale (BFMDRS) before and six months after surgery and by the Patient’s Global Impression of Change Scale postoperatively.

Results: The BFMDRS motor subscore improved by 42%(102/58,5) in case 1; 49%(63/32) in case 2, and  40% (35/21) in case 3. In the gait analysis, all patients’ time to complete the walk decreased after DBS. Patients improved specially in gait stability, balance and posture with overall good impression about the treatment. Speech was not affected by stimulation and no adverse effects were reported.

Conclusion: Our series is the first prospective study of GPi DBS response in patients with a PRKRA mutation. Although robust conclusions are limited because of the small number of cases, our observation supports GPi DBS as a potentially treatment option for DYT16.

References: Albanese A et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol. (2011).
RG, C. et al. Surgical treatment of dystonia. Expert Rev Neurother (2018).
S, T. & KR, K. Pallidal Deep Brain Stimulation for Monogenic Dystonia: The Effect of Gene on Outcome. Front Neurol. (2021).
Camargos, S. et al. DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol. 7, 207–215 (2008).

To cite this abstract in AMA style:

A. Falcone, C. Listik, S. Barbosa Casagrande, M. Torres, D. Boari Coelho, L. Augusto Teixeira, J. Papaterra Limongi, M. Jacobsen Teixeira, E. Reis Barbosa, R. Cury. Deep Brain Stimulation in Generalized Dystonia Caused by PRKRA Mutation [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/deep-brain-stimulation-in-generalized-dystonia-caused-by-prkra-mutation/. Accessed June 12, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/deep-brain-stimulation-in-generalized-dystonia-caused-by-prkra-mutation/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley